N@N

Green Planet Bioengineering Co. Ltd.: Green Planet Announces Entry Into U.S. Public Market

^{Published on 2009-06-17 04:09:13, Last Modified on 2009-06-17 04:10:06 - Market Wire}
 

MIAMI, FL--(Marketwire - June 17, 2009) - Green Planet Bioengineering CO., LTD. (OTCBB: [ GPLB ]) ("Green Planet" or the "Company") a leading bioengineering enterprise dedicated to create high quality chemical intermediates and innovative downstream health products using green processes is pleased to announces its entry into the US public market on the OTCBB.

Green Planet is a high-tech company dedicated to improving health through the research & development, manufacture and commercialization of a broad range of bio-ecological products which include raw chemical intermediates such as Solanesol and its derivative raw CoQ10, fertilizers & pesticides, various plant extracts; and over-the-counter health supplements.

Organic and green products are becoming an increasingly large part of consumers' everyday life. To take advantage of this long-term trend, Green Planet Bio aims to become a leading provider of CoQ10 and bio-ecological health products utilizing abandoned tobacco leaves and various plant extracts. Green Planet is strategically aligned for both organic and acquisition driven growth. Organic growth will come as follows: initially it will be on existing raw chemicals extracted from discarded tobacco leaves by the Company's patented process; and secondly it will be on existing organic agricultural products such as fertilizers and pesticides. External growth will be driven by targeted acquisitions.

"We are very excited to start our entry into the U.S. public market. We have embarked in a dynamic journey and are now well positioned to take Green Planet to the next level in its development," said the Chairman and CEO Mr. Min Zhao. "We are focused on the execution of our business plan which calls for organic as well as acquisition driven growth," added Mr. Zhao.

"We are eager to execute on our growth strategy and deliver health and bio-ecological products. Our goal is to deliver health products that provide various benefits to the human body and bio-ecological products that protect our environment. We look forward to the challenge and our team will continue to strive and over-achieve for our valued shareholders," added Vice President of Sales Sally Ou.

About Green Planet

Green Planet Bioengineering CO., LTD. ("Green Planet") (OTCBB: [ GPLB ]) ([ http://www.greenplanetbio.com ]) through its Chinese subsidiary is a high-tech bioengineering enterprise that engages in research, development, production and sale of various extracts from tobacco leaves residues destined for health and beauty products. Green Planet is headquartered in Miami, FL with its main operation located Sanming and Fuzhou, China. Since founded in 2005, Green Planet now offers a full range of high quality bio-ecological products which include raw chemical materials such as CoQ10 and Solanesol, Organic fertilizers and pesticides and Organic health nutrients and supplements. Company's unique position in the bioengineering industry comes from its R&D using patented cutting-edge methods to create abundant downstream products ranging from plant indigenous medicine, pharmaceutical intermediates to a long list of health products.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Green Planet Bioengineering CO., LTD. takes no obligation to update or correct forward-looking statements.